Arnt−/− mice had significantly more and larger colorectal tumors than WT mice, but blocking CXCR2 with an anti-CXCR2 mAb significantly decreased the incidence of colorectal cancer and delayed the growth of colorectal cancer in mice (Fig. 4F-H). The gene discussed is CXCR2; the disease is colorectal neoplasm.